COA/TZ-2026-017Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Tirzepatide 60 mg
TZ-2026-017Lot NOT PROVIDEDAnalyzed October 29, 2026

Timeline
Ordered
October 26, 2026
Received
October 28, 2026
Analyzed
October 29, 2026
Sample
Name
Tirzepatide 60 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder
Testing
Client
4Ever Research
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
59.04mg
Label claim: 60 mg
Purity, how clean it is
>99.9%
by HPLC-UV peak area
Chromatogram
HPLC-UV
18.59 min, Tirzepatide, >99.9%
Analyst Comments
White lyophilized powder, green-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: October 29, 2026
Verification Code
TZ-1RNE-XIYY
Verify at purilab.org/verify/TZ-1RNE-XIYY
Scan to Verify
TZ-1RNE-XIYY
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1